Oral Presentation ESA-SRB 2023 in conjunction with ENSA

Prevalence and characteristics of low-renin hypertension in an Australian primary care population (#104)

Sonali Shah 1 2 , Renata Libianto 1 2 , Morag J Young 2 , Peter J Fuller 1 2 , Jun Yang 1 2
  1. Department of Endocrinology, Monash Health, Clayton, VIC, Australia
  2. Centre for Endocrinology and Reproductive Health, Hudson Institute of Medical Research, Clayton, VIC , Australia
Publish consent withheld
  1. Ori Y, Chagnac A, Korzets A, Zingerman B, Herman-Edelstein M, Bergman M, Gafter U, Salman H. Regression of left ventricular hypertrophy in patients with primary aldosteronism/low-renin hypertension on low-dose spironolactone. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 2013;28:1787-1793. doi: 10.1093/ndt/gfs587
  2. Libianto R, Russell GM, Stowasser M, Gwini SM, Nuttall P, Shen J, Young MJ, Fuller PJ, Yang J. Detecting primary aldosteronism in Australian primary care: a prospective study. The Medical Journal of Australia. 2022;216:408-412. doi: 10.5694/mja2.51438